From low-pressure relaxation to misplaced sleep cues, expert decodes why the brain winds down on the couch but wakes up in bed, and share simple ways to fix the cycle
MSCI will include Paytm, Fortis Healthcare, GE Vernova T&D India, and Siemens Energy India in its Global Standard Index, triggering over $1.4 billion in passive inflows
The Morgan Stanley Capital International (MSCI) Global Standard Index to include Fortis Healthcare, GE Vernova, Paytm, Siemens Energy from Dec 1, 2205; here's a trading strategy in these 4 stocks.
Ambit analysts see HDFC Bank benefiting from accelerating credit growth, normalisation in cost of funds, and focus on high-yield segments like MSME, gold, and unsecured retail loans.
Domestic brokerage firm Nuvama analysts forecast a modest sequential slowdown but a healthy ~17 per cent year-on-year (Y-o-Y) Ebitda growth, led by hospitals and diagnostics.
Fortis Healthcare has signed a 15-year sub-lease with R.R. Lifesciences to operate a hospital in Greater Noida, expanding its NCR presence with a monthly rent of Rs 2.4 crore
Stocks to Watch today, August 21, 2025: From India Cements to Clean Science and Technology, here are a few stocks that investors and traders will eye; check the full list
Fortis Healthcare Q1FY26 profit rises 53% to ₹266.78 crore as hospital and diagnostics businesses drive 16.6% revenue growth and Ebitda margin improves to 22.6%
Q1 FY26 company results, August 6: Bayer CropScience, Cera Sanitaryware, EID Parry India, Godrej Agrovet, and Pidilite are also to release their April-June quarter earnings reports today
Stocks to Buy, June 19: Ajit Mishra of Religare Broking suggests buying Bharti Airtel and Fortis Healthcare shares, but advises selling Futures of HUL. Read to find out his market view & stock picks
Analysts say IHH's reputational harm claim in Japan won't impact Fortis's Indian operations; litigation continues over stalled open offer and regulatory hurdles
The hospital chain's revenue rose 12.4% to Rs 2,007 crore in Q4 FY25 driven by hospital and diagnostics segments, but higher expenses and impairments hit net profit
The board of directors of the company have recommended a final dividend of ₹1 per equity share for the financial year 2024-25, subject to the approval of shareholders
The latest petition filed by NTK seeks another 2.7 million rupees for losses arising from the unit's defamation claim against Daiichi Sankyo and accrued interest on the damages claimed
Q4 FY25 company results today: Zydus Lifesciences, Fortis Healthcare, and Torrent Pharma will be among 146 companies to post earnings reports for the January-March quarter
The red cross, a globally recognised symbol protected under the Geneva Conventions, is being painted on hospital rooftops to mark them as non-targets amid escalating border tensions
Shivinder Singh, along with his elder brother Malvinder Singh, was once among the richest businessmen in India. The duo gained prominence after selling controlling stake in Ranbaxy Laboratories
